In addition to imaging devices such as ultrasound, CT, and MRI, biomarkers increasingly play a role in the early diagnosis of They help to predict hepatocellular carcinoma in cases of chronic hepatitis B, C or cirrhosis, to monitor patients after treatment and to detect recurrences.